6-Oxo-1-(3-(trifluoromethyl)benzyl)-1,6-dihydropyridine-3-carbaldehyde

Catalog No. :
ACRUOL615
CAS No. :
952183-57-2
Molecular Formula :
C14H10F3NO2
Molecular Weight :
281.23

IUPAC Name:6-oxo-1-(3-(trifluoromethyl)benzyl)-1,6-dihydropyridine-3-carbaldehyde

6-Oxo-1-(3-(trifluoromethyl)benzyl)-1,6-dihydropyridine-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$771.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Oxo-1-(3-(trifluoromethyl)benzyl)-1,6-dihydropyridine-3-carbaldehyde
IUPAC Name6-oxo-1-(3-(trifluoromethyl)benzyl)-1,6-dihydropyridine-3-carbaldehyde
MDL No.MFCD09817436
Molecular FormulaC14H10F3NO2
Molecular Weight281.23
SMILESO=CC(C=C1)=CN(CC2=CC=CC(C(F)(F)F)=C2)C1=O
InChI KeyGVAAKVLOUBEGIP-UHFFFAOYSA-N
Synonym6-oxo-1-[3-(trifluoromethyl)benzyl]-1,6-dihydro-3-pyridinecarbaldehyde;6-oxo-1-{[3-(trifluoromethyl)phenyl]methyl}-1,6-dihydropyridine-3-carbaldehyde;6-oxo-1-[[3-(trifluoromethyl)phenyl]methyl]pyridine-3-carbaldehyde;3-Pyridinecarboxaldehyde, 1,6-dihydro-6-oxo-1-[[3-(trifluoromethyl)phenyl]methyl]-
CAS No.952183-57-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACRUOL615 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDFCU721 route compound structure diagram
    ACDFCU721106984-91-2 In Stock
  4. Then
  5. ACRUOL615 route product structure diagram
    ACRUOL615952183-57-2
Inquiry

2. ACRUOL615 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRUOL615 route product structure diagram
    ACRUOL615952183-57-2
Inquiry

Comments (0)